Share:
Peer-Reviewed Publication
Res Sq2026March 4, 2026Journal Article

MUC16-dependent Renal Vascular Adhesion of Candida Promotes Tissue Invasion and Predicts Clinical Outcome in Candidemia.

Peter Williamson1, Jin Qiu2, Shellee Grim3, Guowu Hu2, Yoon-Dong Park2, Melissa Johnson4, Sunita Paaudel5, Troy Stevens5, John Perfect6, Visiliki Matzaraki7, Vinod Kumar8, Frank van de Veerdonk9, Mihai Netea9, Michail Lionakis10, Adebo Adebowale2, Scott Filler11, Nina Clark12, Ernesto Cota13
1National institutes of Health.
2National Institutes of Health.
3Wolters Kluwer Health.
4Duke University Medical Center.
5University of South Alabama College of Medicine.
6Duke University.
7Radboud Center for Infectious Diseases.
8Radboud University Medical Center, Nijmegen.
9Radboud University Nijmegen Medical Centre.
10National Institute of Allergy and Infectious Diseases.
11Lundquist Institute for Biomedical Innovation at Harbor-UCLA.
12University of Illinois at Chicago.
13Imperial College, London.

Abstract

Bloodstream infection with Candida species is associated with high mortality, yet the molecular basis of vascular adhesion and invasion remains unclear. We identify the endothelial surface mucin MUC16 as a key host factor enabling fungal vascular adherence. The MUC16 SEA domain directly engages the Candida adhesin Als3p and endothelial N-cadherin to form a ternary complex that promotes endothelial…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.